Ampio Pharmaceuticals Inc (AMPE):企業の財務・戦略的SWOT分析

◆英語タイトル:Ampio Pharmaceuticals Inc (AMPE) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15092
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ampio Pharmaceuticals Inc (Ampio), formerly Chay Enterprises Inc is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company develops compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level. It provides products for the treatment of osteoarthritis, diabetic macular edema, and other prevalent, inflammatory diseases. Ampio’s products include low molecular weight fraction of human serum albumin and ultra-low dose of danazol. Its ultra-low dose of danazol is used for the oral treatment of diabetic macular edema. The company conducts research on various future indications for optina. It partners with other biopharmaceutical companies for its research activities. Ampio is headquartered in Englewood, Colorado, the US.

Ampio Pharmaceuticals Inc Key Recent Developments

Sep 12,2018: Ampio Reports Manuscript on the Mechanisms of Action (MOA) for Ampion™ accepted for Publication in “Clinical and Experimental Rheumatology™”
May 14,2018: Ampio Provides Corporate Update
Mar 15,2018: Ampio Pharmaceuticals Provides Corporate Update Following Conference Call

This comprehensive SWOT profile of Ampio Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ampio Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Ampio Pharmaceuticals Inc – Key Information
Ampio Pharmaceuticals Inc – Overview
Ampio Pharmaceuticals Inc – Key Employees
Ampio Pharmaceuticals Inc – Key Employee Biographies
Ampio Pharmaceuticals Inc – Key Operational Heads
Ampio Pharmaceuticals Inc – Major Products and Services
Ampio Pharmaceuticals Inc – History
Ampio Pharmaceuticals Inc – Company Statement
Ampio Pharmaceuticals Inc – Locations And Subsidiaries
Ampio Pharmaceuticals Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Ampio Pharmaceuticals Inc – Business Description
Ampio Pharmaceuticals Inc – Corporate Strategy
Ampio Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Ampio Pharmaceuticals Inc – Strengths
Ampio Pharmaceuticals Inc – Weaknesses
Ampio Pharmaceuticals Inc – Opportunities
Ampio Pharmaceuticals Inc – Threats
Ampio Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Ampio Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Ampio Pharmaceuticals Inc, Key Information
Ampio Pharmaceuticals Inc, Key Ratios
Ampio Pharmaceuticals Inc, Share Data
Ampio Pharmaceuticals Inc, Major Products and Services
Ampio Pharmaceuticals Inc, History
Ampio Pharmaceuticals Inc, Key Employees
Ampio Pharmaceuticals Inc, Key Employee Biographies
Ampio Pharmaceuticals Inc, Key Operational Heads
Ampio Pharmaceuticals Inc, Other Locations
Ampio Pharmaceuticals Inc, Subsidiaries
Ampio Pharmaceuticals Inc, Key Manufacturing facilities
Ampio Pharmaceuticals Inc, Key Competitors
Ampio Pharmaceuticals Inc, SWOT Analysis
Ampio Pharmaceuticals Inc, Ratios based on current share price
Ampio Pharmaceuticals Inc, Annual Ratios
Ampio Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Ampio Pharmaceuticals Inc, Performance Chart
Ampio Pharmaceuticals Inc, Ratio Charts

★海外企業調査レポート[Ampio Pharmaceuticals Inc (AMPE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Magyar Nemzeti Bank:企業の戦略的SWOT分析
    Magyar Nemzeti Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Pharmaron Beijing Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmaron Beijing Co Ltd (Pharmaron) is a life science service company that provides drug research and development services in the areas of chemistry, biology, pharmacology, DMPK, toxicology, and chemical development. The company's service offerings include synthetic, medicinal and analytica …
  • Casino Guichard-Perrachon SA:企業のM&A・事業提携・投資動向
    Casino Guichard-Perrachon SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Casino Guichard-Perrachon SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • 1-800-FLOWERS.COM, Inc.:企業の戦略・SWOT・財務情報
    1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report Summary 1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Clicks Group Limited:企業の戦略・SWOT・財務分析
    Clicks Group Limited - Strategy, SWOT and Corporate Finance Report Summary Clicks Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Actelion Ltd:企業の戦略・SWOT・財務情報
    Actelion Ltd - Strategy, SWOT and Corporate Finance Report Summary Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Senhwa Biosciences Inc (6492):製薬・医療:M&Aディール及び事業提携情報
    Summary Senhwa Biosciences Inc (Senhwa) is a clinical stage drug development company that develops next generation DNA damage response drugs for the treatment of cancer. The company’s pipeline products include CX-5461 and CX-4945. Its CX-5461, a G4-stabilizing compound, is a Pol I inhibitor that tri …
  • Yomeishu Seizo Co Ltd (2540):企業の財務・戦略的SWOT分析
    Yomeishu Seizo Co Ltd (2540) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Immunodiagnostic Systems Holdings plc (IDH)-医療機器分野:企業M&A・提携分析
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • EMIS Group plc (EMIS):企業の財務・戦略的SWOT分析
    Summary EMIS Group Plc (EMIS), formerly Egton Medical Information Systems Ltd, is a provider of information technology and related services. The company provides electronic patient record systems and software solutions such as EMIS web, used for clinical services; EMIS IQ for data extraction; and sy …
  • B2W – Companhia Global Do Varejo:企業の戦略・SWOT・財務分析
    B2W - Companhia Global Do Varejo - Strategy, SWOT and Corporate Finance Report Summary B2W - Companhia Global Do Varejo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Pick N Pay Stores Limited:企業の戦略・SWOT・財務分析
    Pick N Pay Stores Limited - Strategy, SWOT and Corporate Finance Report Summary Pick N Pay Stores Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Penn United Technologies, Inc.:企業の戦略・SWOT・財務情報
    Penn United Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Penn United Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • NovaBay Pharmaceuticals Inc (NBY):企業の財務・戦略的SWOT分析
    Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products. The company’s products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures. Its daily lid a …
  • Petro Matad Ltd (MATD):企業の財務・戦略的SWOT分析
    Summary Petro Matad Ltd (Petro Matad) is an oil and gas company that develops and operates oil and gas exploration properties. The company’s upstream oil and gas exploration asset base includes Block IV, Block XX, and Block V. Its Block XX is located in the far eastern part of Mongolia producing oil …
  • Sensus Healthcare Inc (SRTS):製品パイプライン分析
    Summary Sensus Healthcare Inc (Sensus), previously Sensus Healthcare LLC, designs, manufactures, and markets proprietary medical devices for the treatment of various types of cancers and skin diseases. The company offers superficial radiation therapy (SRT) technology based non-surgical treatment opt …
  • SK Networks Co Ltd (001740):企業の財務・戦略的SWOT分析
    Summary SK Networks Co Ltd (SK Networks) is a marketing and distribution company. The company operates in diversified businesses including ICT marketing, automotive, hotel and resorts, rental appliances, and chemical material. It offers global trading in industrial materials such as steel, chemicals …
  • Omega Pharma NV-製薬・医療分野:企業M&A・提携分析
    Summary Omega Pharma NV (Omega Pharma), a subsidiary of Perrigo Company plc, is a pharmaceutical company focusing on the development, manufacture and sale of prescription-free or Over the Counter (OTC) health and personal care products. The company's product portfolio includes cough and cold product …
  • EuroSibEnergo Plc:企業の戦略的SWOT分析
    EuroSibEnergo Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Talktalk Telecom Group PLC (TALK):企業の戦略的SWOT分析
    Talktalk Telecom Group PLC (TALK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆